UNSPSC 51111729: Arsenic trioxide

This classification denotes a differentiation inducer, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S7V92P67HO. European Medicines Agency schedules Arsenic trioxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12467MIG. Arsenic trioxide generally arises in the molecular formula AS2O3. The term ARSENIC TRIOXIDE is a United States Adopted Name designation. Most nations schedule arsenic trioxide under HS 28112990 and SITC 52239.

As of Q4 2014, ARSENIC TRIOXIDE remains the US FDA Preferred Term for this commodity. Arsenic trioxide bears US NLM identifiers UMLS ID C0052416 and NCI Concept Code C1005. SMILES: O1[As]2O[As]1O2.

UNSPSC 51111729 Arsenic trioxide is a Commodity code that shows little relevant recent activity in state and local procurement. The recent opportunities tagged under this code—naloxone and drug deactivation systems, direct-to-manufacturer pharmacy initiatives, medical and first aid supplies for emergency response, and generic pharmaceuticals through cooperative purchasing—fall outside arsenic trioxide's actual scope as a chemical compound used primarily in oncology and specialized medical applications. State and local governments do not appear to be soliciting arsenic trioxide itself through open market procurements; the code assignment in these notices reflects broad pharmaceutical or medical-supply categorization rather than specific demand for this commodity.

The misalignment between the code's nominal scope and the work actually being bought signals that arsenic trioxide does not represent a meaningful procurement opportunity for vendors targeting state and local markets at present. The opportunities recorded under this code involve high-volume consumables (naloxone kits, first aid supplies, generic OTC products) and pharmacy benefit contracting—categories that dwarf any institutional demand for a specialized oncology pharmaceutical. Business development professionals evaluating this code should verify independently whether their target jurisdictions solicit arsenic trioxide through dedicated health system purchasing or cooperative agreements; the public notice record does not support active, regular procurement activity in this commodity.